Neslihan Akdoğan

523 total citations
56 papers, 272 citations indexed

About

Neslihan Akdoğan is a scholar working on Dermatology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Neslihan Akdoğan has authored 56 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Dermatology, 15 papers in Rheumatology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Neslihan Akdoğan's work include Autoimmune Bullous Skin Diseases (8 papers), Urticaria and Related Conditions (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Neslihan Akdoğan is often cited by papers focused on Autoimmune Bullous Skin Diseases (8 papers), Urticaria and Related Conditions (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). Neslihan Akdoğan collaborates with scholars based in Türkiye, Austria and United States. Neslihan Akdoğan's co-authors include Başak Yalçın, Sibel Doğan, Nuran Allı, Yıldız Hayran, Sibel Ersoy Evans, Turan Turhan, Tuba Çandar, Nilgün Atakan, Başak Yalıcı‐Armağan and Canan Topçuoğlu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Dermatologic Surgery and The American Journal of Emergency Medicine.

In The Last Decade

Neslihan Akdoğan

48 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neslihan Akdoğan Türkiye 10 158 65 58 56 47 56 272
Parvaneh Hatami Iran 11 168 1.1× 37 0.6× 51 0.9× 87 1.6× 29 0.6× 58 352
Emin Özlü Türkiye 11 167 1.1× 25 0.4× 41 0.7× 65 1.2× 40 0.9× 42 308
Ömer Faruk Elmas Türkiye 10 180 1.1× 35 0.5× 30 0.5× 54 1.0× 84 1.8× 79 345
Didem Didar Balcı Türkiye 9 174 1.1× 43 0.7× 30 0.5× 95 1.7× 44 0.9× 26 306
Brett Sloan United States 9 103 0.7× 36 0.6× 38 0.7× 14 0.3× 101 2.1× 33 321
Alfred Ammoury Lebanon 12 172 1.1× 27 0.4× 56 1.0× 57 1.0× 127 2.7× 36 376
Rosa Fernández‐Torres Spain 11 143 0.9× 65 1.0× 30 0.5× 91 1.6× 65 1.4× 19 260
K. Katzer Germany 8 335 2.1× 66 1.0× 125 2.2× 93 1.7× 28 0.6× 10 466
Hideki Mukai Japan 10 123 0.8× 21 0.3× 38 0.7× 23 0.4× 76 1.6× 27 280
Camilla Loi Italy 8 70 0.4× 20 0.3× 35 0.6× 50 0.9× 57 1.2× 32 201

Countries citing papers authored by Neslihan Akdoğan

Since Specialization
Citations

This map shows the geographic impact of Neslihan Akdoğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neslihan Akdoğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neslihan Akdoğan more than expected).

Fields of papers citing papers by Neslihan Akdoğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neslihan Akdoğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neslihan Akdoğan. The network helps show where Neslihan Akdoğan may publish in the future.

Co-authorship network of co-authors of Neslihan Akdoğan

This figure shows the co-authorship network connecting the top 25 collaborators of Neslihan Akdoğan. A scholar is included among the top collaborators of Neslihan Akdoğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neslihan Akdoğan. Neslihan Akdoğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Balan, Kerem, et al.. (2025). Poikiloderma With Neutropenia due to Novel USB1 Mutation. Pediatric Dermatology. 42(6). 1227–1230.
3.
4.
Bostan, Ecem, Neslihan Akdoğan, Başak Yalıcı‐Armağan, et al.. (2022). Monitoring Serum Lipid Profile and Liver Transaminase Levels During Isotretinoin Therapy. 53(2). 110–113. 2 indexed citations
5.
Akdoğan, Neslihan, et al.. (2022). Extradigital Glomus Tumor of the Arm. Dermatologic Surgery. 48(10). 1119–1120. 2 indexed citations
6.
Akdoğan, Neslihan, et al.. (2022). New Onset Mitral Regurgitation Caused by Mitral Valve Prolapse in a Male Patient with Dominant Pretibial Dystrophic Epidermolysis Bullosa. Indian Journal of Dermatology. 67(1). 72–74. 1 indexed citations
7.
Yalıcı‐Armağan, Başak, et al.. (2021). Treatment of psoriasis with biologics in the early COVID‐19 pandemic: A study examining patient attitudes toward the treatment and disease course. Journal of Cosmetic Dermatology. 20(10). 3098–3102. 4 indexed citations
8.
Akdoğan, Neslihan, Sibel Doğan, Ecem Bostan, et al.. (2021). Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasis. Expert Review of Clinical Pharmacology. 14(12). 1535–1541. 4 indexed citations
9.
Akdoğan, Neslihan, Sibel Ersoy Evans, Özay Özkaya, Yunus Erdem, & Serdar Nasır. (2021). Early recognition of chronic rejection in a face allotransplant patient with alopecia. Journal of Cutaneous Pathology. 48(10). 1286–1297. 5 indexed citations
10.
Akdoğan, Neslihan, et al.. (2021). Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real‐life data from a single centre. International Journal of Clinical Practice. 75(12). e14955–e14955. 1 indexed citations
11.
Akdoğan, Neslihan, et al.. (2021). Sarcoid-like granulomatous reaction in the lung mimicking miliary tuberculosis in a patient receiving adalimumab for psoriasis. Archives of Rheumatology. 36(3). 461–463. 1 indexed citations
12.
Bostan, Ecem, Sibel Doğan, Başak Yalıcı‐Armağan, et al.. (2020). Lactate dehydrogenase, Beta-2 Microglobulin Levels and CD4/CD8 Lymphocyte Ratio in Patients with Mycosis Fungoides in Stage 1A. 51(4). 16–21. 2 indexed citations
13.
Akdoğan, Neslihan, Sibel Doğan, Başak Yalıcı‐Armağan, et al.. (2020). Serial Quantiferon‐TB Gold test results in 279 patients with psoriasis receiving biologic therapy. Dermatologic Therapy. 34(1). e14699–e14699. 5 indexed citations
14.
Akdoğan, Neslihan, et al.. (2020). Mucous membrane pemphigoid in a patient treated with nivolumab for Hodgkin's lymphoma. Dermatologic Therapy. 33(6). e14109–e14109. 3 indexed citations
15.
Akdoğan, Neslihan, et al.. (2020). Successful treatment of a patient with linear IgA bullous dermatosis limited to oral, hypopharyngeal, and laryngeal mucosa with dapsone. Dermatologic Therapy. 33(6). e14127–e14127. 1 indexed citations
16.
Akdoğan, Neslihan, Sibel Doğan, & Nilgün Atakan. (2019). Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study. Journal of Dermatological Treatment. 31(7). 702–706. 3 indexed citations
17.
Akdoğan, Neslihan, Sibel Ersoy Evans, Sibel Doğan, & Nilgün Atakan. (2019). Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata. Dermatologic Therapy. 32(6). e13118–e13118. 11 indexed citations
18.
Akdoğan, Neslihan, et al.. (2019). Factors Affecting the Etiology of Intractable Pruritus in Hospitalized Patients Without Primary Skin Lesions. SHILAP Revista de lepidopterología. 20(3). 224–230. 2 indexed citations
19.
Akdoğan, Neslihan, et al.. (2018). Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case–control study. Archives of Dermatological Research. 310(10). 785–793. 26 indexed citations
20.
Akdoğan, Neslihan, et al.. (2018). Educational level and job status are the most important factors affecting compliance with oral antihistamine therapy for patients with chronic urticaria. Journal of Dermatological Treatment. 30(2). 183–188. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Parvaneh Hatami Breakdown of academic impact, for papers by Emin Özlü Breakdown of academic impact, for papers by Ömer Faruk Elmas Breakdown of academic impact, for papers by Didem Didar Balcı Breakdown of academic impact, for papers by Brett Sloan Breakdown of academic impact, for papers by Alfred Ammoury Breakdown of academic impact, for papers by Rosa Fernández‐Torres Breakdown of academic impact, for papers by K. Katzer Breakdown of academic impact, for papers by Hideki Mukai Breakdown of academic impact, for papers by Camilla Loi
Rankless by CCL
2026